← Open Payments lookup

FARLEY BROWN: Open Payments

NPI 1265467385 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$862 in 31 payments from 12 companies in 2025. Trend: 2023 $1,231 · 2024 $630 · 2025 $862

Food & beverage: $842Education: $20
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$243
Bayer Healthcare Pharmaceuticals Inc.8$241
Novo Nordisk Inc3$165
TOLMAR, INC.3$49
AstraZeneca Pharmaceuticals LP3$46
Exact Sciences Corporation1$20
Gilead Sciences, Inc.1$19
Otsuka America Pharmaceutical, Inc.1$18
ABBVIE INC.1$17
Astellas Pharma US Inc1$16

Products named: CAPLYTA, Kerendia, Ozempic, JATENZO, The Cologuard Plus Collection Kit, REXULTI, AIRSUPRA, VRAYLAR.

Industry payments across TX — which companies pay providers there.